Puberty blockers: "Little is known about its safety profile in the context of gender dysphoria: use is based largely on effects of treatment of central precocious puberty."
-
Show this thread
-
"Evidence suggests that children will change their minds as they age: approximately ¾ of pre-pubescent children attending gender identity clinics will not want to change their gender once puberty starts."
1 reply 2 retweets 26 likesShow this thread -
Out of ten studies that analysed the effects of puberty blockers, six studies were funded by industry: 4 received funding from Ferring. "The denominators in all of these ten studies are tiny and mostly from retrospective case reports or small case series."
1 reply 2 retweets 23 likesShow this thread -
"Many are done in single clinics and lack long term longitudinal outcomes on the effects (both benefits and harms) of puberty blockers." "We found four studies reporting on the use of GnHRa alone."
1 reply 1 retweet 17 likesShow this thread -
"Problems within these studies, however, make it difficult to assess whether early pubertal changes regress under GnRHa treatment and whether prolonged puberty suppression is safe." For example, lack of controls and lack of blinding means results are unclear.
1 reply 2 retweets 20 likesShow this thread -
Without controls we can't say for certain that improvement in psychosocial well-being is an effect of hormonal treatment: getting older is also positively associated with maturity and well-being.
1 reply 2 retweets 21 likesShow this thread -
Oestrogens and testosterone "SHOULD ONLY BE taken in the context of medical supervision to monitor risks." "Neuroimaging studies suggest CSHs affect brain structure and circuitries, ventricular volume and thickness, hypothalamic neuroplasticity, and functional connectivity."
2 replies 1 retweet 17 likesShow this thread -
The DeVries studies (2011, 2014) are used by activists to prove benefits of hormonal treatments. Conclusion here: "High levels of bias with study participation mean the results should be treated with caution." This was a very carefully selected cohort to start with.
1 reply 3 retweets 19 likesShow this thread -
Conclusions: "There are significant problems with how the evidence for Gender-affirming cross-sex hormone has been collected and analysed that prevents definitive conclusions to be drawn."
1 reply 2 retweets 21 likesShow this thread -
Problems include: small sample sizes; retrospective methods, loss of considerable numbers of patients in follow-up, lack of control groups and blinding, subjective outcomes prone to bias which can be explained by regression to the mean.
1 reply 2 retweets 34 likesShow this thread
Treatments "remain largely experimental. There are a large number of unanswered questions that include the age at start, reversibility; adverse events, long term effects on mental health, quality of life, bone mineral density, osteoporosis in later life and cognition."
Loading seems to be taking a while.
Twitter may be over capacity or experiencing a momentary hiccup. Try again or visit Twitter Status for more information.